Stockscreener 앱 받기
3.68
7.29%
0.25
시장 영업 전:
3.68
전일 마감가:
$3.43
열려 있는:
$3.46
하루 거래량:
468.37K
Relative Volume:
0.67
시가총액:
$370.21M
수익:
-
순이익/손실:
$-60.14M
주가수익비율:
-5.1868
EPS:
-0.7095
순현금흐름:
$-68.17M
1주 성능:
+17.20%
1개월 성능:
+31.43%
6개월 성능:
+84.92%
1년 성능:
+25.60%
1일 변동 폭
$3.45
$3.70
1주일 범위
$3.09
$3.73
52주 변동 폭
$1.4299
$4.00
Ac Immune Sa Stock (ACIU) Company Profile
ACIU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
3.68 | 345.06M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-31 | 개시 | BTIG Research | Buy |
| 2019-02-01 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-01-04 | 개시 | UBS | Buy |
| 2018-04-05 | 개시 | H.C. Wainwright | Buy |
| 2018-03-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | 개시 | Credit Suisse | Outperform |
| 2016-10-18 | 개시 | Jefferies | Buy |
| 2016-10-18 | 개시 | Leerink Partners | Outperform |
모두보기
Ac Immune Sa 주식(ACIU)의 최신 뉴스
Why is AC Immune stock up over 23% today? - MSN
Short Interest in AC Immune (NASDAQ:ACIU) Grows By 94.4% - MarketBeat
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - MSN
Market Leaders: Will AC Immune SA stock split again soonMarket Trend Review & High Return Stock Watch Alerts - moha.gov.vn
AC Immune (STU:IMR) EV-to-OCF : -3.79 (As of Jan. 06, 2026) - GuruFocus
AC Immune (NASDAQ:ACIU) Trading Up 5%Should You Buy? - MarketBeat
Why ETFs are accumulating AC Immune SA (IMR) stockTechnical Breakout Signals & Free High Impact Stock Picks - bollywoodhelpline.com
Why AC Immune SA stock remains a top recommendationPortfolio Value Report & Real-Time Stock Entry Alerts - Улправда
New Highs: Will AC Immune SA stock recover faster than marketWeekly Investment Summary & Real-Time Volume Trigger Notifications - Улправда
How AC Immune SA stock responds to policy changesPortfolio Return Report & Daily Profit Maximizing Tips - Улправда
Why analysts upgrade AC Immune SA stock2025 Year in Review & AI Enhanced Market Trend Forecasts - Улправда
Will AC Immune SA stock split again soon2025 Risk Factors & High Accuracy Swing Trade Signals - DonanımHaber
Will AC Immune SA (IMR) stock boost dividends further2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Should I hold or sell AC Immune SA stock in 2025Market Performance Report & Consistent Income Trade Recommendations - DonanımHaber
Is AC Immune SA stock supported by strong fundamentals2025 Bull vs Bear & Free Community Consensus Stock Picks - Bölüm Sonu Canavarı
Recap Report: Why analysts upgrade AC Immune SA stockWeekly Investment Summary & Growth Oriented Trading Recommendations - ulpravda.ru
Aug Update: Will AC Immune SA stock recover faster than market2025 Market Sentiment & Safe Capital Allocation Plans - Улправда
AC Immune (STU:IMR) OCF Margin % : -1,953.03% (As of Sep. 2025) - GuruFocus
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD - Seeking Alpha
AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Performance Recap: Will AC Immune SA stock outperform growth indexesJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - moha.gov.vn
Aug Macro: Will AC Immune SA IMR stock outperform value peers2025 Technical Overview & Precise Swing Trade Alerts - moha.gov.vn
AC Immune Perks Up On Positive Parkinson’s Data - Citeline News & Insights
AC Immune reports promising phase 2 results for Parkinson’s therapy - MSN
AC Immune’s Parkinson’s vaccine advances on promising biomarker profile - BioCentury
AC Immune Simulates Curiosity in Neurodegenerative Fight with Global Conference Plans - StocksToTrade
AC Immune (ACIU) Stock: Surges as ACI-7104.056 Shows Potential in Early Parkinson’s Disease - parameter.io
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - Benzinga
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results - TipRanks
Why Is AC Immune Stock Up Over 23% Today? - Asianet Newsable
AC Immune SA: Navigating Market Momentum - timothysykes.com
ACIU Surges 30% on Positive Parkinson's Therapy Trial Results - GuruFocus
ACIU: ACI-7104.056 shows promise in slowing Parkinson's progression with strong safety and efficacy - TradingView
AC Immune’s Parkinson’s treatment shows promise in slowing disease - Investing.com
AC Immune surges on positive mid-stage trial data for Parkinson’s drug - Seeking Alpha
AC Immune (ACIU) Reports Encouraging Phase 2 Results for Parkins - GuruFocus
Ac Immune shares climb 32.6% premarket after co reports positive trial data for Parkinson's disease therapy - marketscreener.com
AC Immune stock rises after positive Parkinson’s disease trial data - Investing.com India
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy - TipRanks
AC Immune’s Parkinson’s treatment shows promise in slowing disease By Investing.com - Investing.com Canada
AC Immune Reports Positive Interim Phase 2 Data for ACI-7104.056 Indicating Potential to Slow Parkinson's Disease Progression - Quiver Quantitative
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - The Manila Times
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - GlobeNewswire Inc.
AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy - simplywall.st
Sentiment Watch: Will AC Immune SA stock deliver long term returns - moha.gov.vn
Aug Reactions: Why ETFs are accumulating AC Immune SA IMR stockEarnings Risk Summary & Daily Stock Trend Watchlist - BỘ NỘI VỤ
Quarterly Risk: Why analysts upgrade AC Immune SA stock2025 Sector Review & Fast Momentum Stock Entry Tips - BỘ NỘI VỤ
How AC Immune SA (IMR) stock reacts to weak economyVolume Spike & Weekly High Potential Alerts - Newser
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Is AC Immune SA (IMR) stock a top dividend aristocrat candidate2025 Short Interest & Reliable Price Action Trade Plans - Newser
How big funds are accumulating AC Immune SA (IMR) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser
Ac Immune Sa (ACIU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):